|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 49/00 | (2006.01) |
| A61K 38/00 | (2013.01) | ||
| C07K 14/00 | (2006.01) | ||
| C07K 14/78 | (2013.01) | ||
| C40B 50/00 | (2006.01) | ||
| C12N 15/1044 | (2013.01) | ||
| A61P 1/00 | (2018.01) | ||
| C40B 40/08 | (2006.01) | ||
| A61P 11/00 | (2018.01) | ||
| C40B 40/02 | (2006.01) | ||
| A61P 11/02 | (2018.01) | ||
| C40B 30/04 | (2006.01) | ||
| A61P 25/00 | (2018.01) | ||
| C07H 21/00 | (2006.01) | ||
| C12N 15/63 | (2006.01) | ||
| A61P 27/00 | (2018.01) | ||
| C12N 1/21 | (2006.01) | ||
| A61P 27/02 | (2018.01) | ||
| C12N 1/19 | (2006.01) | ||
| A61P 27/16 | (2018.01) | ||
| C12N 5/10 | (2006.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61K 38/16 | (2006.01) | ||
| A61P 3/00 | (2018.01) | ||
| A61P 25/00 | (2006.01) | ||
| A61P 31/00 | (2018.01) | ||
| A61K 38/22 | (2006.01) | ||
| A61P 31/04 | (2018.01) | ||
| A61P 7/00 | (2006.01) | ||
| A61P 31/12 | (2018.01) | ||
| A61P 27/02 | (2006.01) | ||
| A61P 33/00 | (2018.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 9/00 | (2006.01) | ||
| A61P 37/00 | (2018.01) | ||
| A61P 37/02 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 7/00 | (2018.01) | ||
| A61P 9/00 | (2018.01) | ||
| A61P 9/10 | (2018.01) | ||
| Y02A 50/30 | (2018.01) |
| (11) | Patento numeris | 3569256 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19169579.0 |
| Europos patento paraiškos padavimo data | 2011-04-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-11-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-06-15 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 32998010 P | 2010-04-30 | US |
| (72) |
JACOBS, Steven , US
|
| (73) |
Janssen Biotech, Inc. ,
800/850 Ridgeview Drive, Horsham, PA 19044,
US
|
| (54) | STABILIZED FIBRONECTIN DOMAIN COMPOSITIONS, METHODS AND USES |
| STABILIZED FIBRONECTIN DOMAIN COMPOSITIONS, METHODS AND USES |